IPO Renaissance IPO ETF

Expense Ratio
0.6%
Dividend
0.44%
Previous close
$53.71
Est. 12 months change
+32.96%
Projected Price
$71.41

Profitability Metrics

Return on Equity (ROE)
21.16%
Return on Assets (ROA)
6.56%
Return on Invested Capital (ROIC)
28.27%
Weighted Average Cost of Capital (WACC)
15.91%
ROIC - WACC
12.36%
Updated : 2026-09-26 07:50 ET

Valuation Metrics

P/E Ratio
26.31
Forward P/E
19.01
PEG Ratio
1.73
Debt Current Ratio
4.73

Growth & Cash Flow

Gross Margin
57.91%
Operating Margin
-146.43%
FCF Margin
23.30%
TTM Revenue Growth
76.19%
Projected 12M EPS Growth
38.41%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
ALAB11.89%
SKHY9.79%
SPCX9.75%
CRWV6.80%
RDDT5.37%
RBRK4.36%
CRCL4.25%
MDLN3.88%
VIK3.60%
KSPI2.58%

ETF Analysis

Fund Overview

Renaissance IPO ETF (IPO) currently reports 55 stock positions (subject to change), placing it in the moderately diversified range by holdings breadth. The top line-up is ALAB (11.89%), SKHY (9.79%), SPCX (9.75%), with ALAB as the largest single weight at 11.89%. Together, the top three holdings account for 31.43%, which signals meaningful concentration at the top of the book, where a small number of names can drive outsized swings in fund performance. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 28.27%, WACC is 15.91%, and the economic spread is 12.36%. On balance, holdings generate meaningful returns above their cost of capital, a hallmark of competitively advantaged businesses. Supporting metrics show ROE at 21.16% and ROA at 6.56%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Turning to how the market is pricing the underlying earnings, trailing P/E of 26.31, forward P/E of 19.01, PEG of 1.73. A moderate trailing-to-forward spread implies earnings growth is anticipated, though the scale of expected improvement is not dramatic. A PEG in this range suggests valuation is fair rather than compelling — the portfolio is priced adequately for its growth, with limited buffer for downside revisions. The current ratio of 4.73 indicates holdings are well-positioned to meet near-term obligations. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.

Margins & Cash Generation

On the margin front: gross margin sits at 57.91%, operating margin at -146.43%, and free cash flow margin at 23.30%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. The operating margin reading is weak, suggesting cost structures are outpacing revenue generation across much of the portfolio. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.

Growth & Forward Outlook

The two main inputs to the near-term picture — TTM revenue growth of 76.19% reflecting robust top-line expansion across the underlying holdings. Consensus EPS estimates point to 38.4% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations point to meaningful upside if execution holds on a 12-month view. Revenue momentum establishes the baseline; analyst price targets reveal how much the market is already paying for future execution on top of that baseline. Delivered returns will ultimately be shaped by the gap — or lack thereof — between operating execution and the expectations embedded in current prices. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.